Publication | Closed Access

Network-based drug repurposing identifies small molecule drugs as immune checkpoint inhibitors for endometrial cancer

Drug RepositioningMedicineImmune Checkpoint InhibitorsNetwork-based DrugImmune Checkpoint InhibitorCancer TreatmentEndometrial CancerSystems BiologyOncologyRadiation OncologyTumor MicroenvironmentCancer Research